Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection

Hepatology

Volumn 46, Issue 1, 2007, Pages 107-112

  Yood, Marianne Ulcickas ^a,b,c,g   Quesenberry Jr , Charles P ^d   Guo, Dianlin ^e   Caldwell, Cary ^f   Wells, Karen ^a   Shan, Jun ^d   Sanders, Lynn ^e   Skovron, Mary Lou ^e   Iloeje, Uchenna ^e   Manos, M Michele ^d  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EpiSource   (United States)

^d DIVISION OF RESEARCH   (United States)

^e BRISTOL MYERS SQUIBB   (United States)

^f YALE NEW HAVEN HOSPITAL   (United States)

^g NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HEPATITIS B; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LABORATORY TEST; LIVER BIOPSY; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; UNITED STATES;

ADULT; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; HEPATITIS B, CHRONIC; HUMANS; INCIDENCE; LIVER NEOPLASMS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; UNITED STATES;

EID: 34547435360     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21642     Document Type: Article

References (24)

1. Cancer Facts & Figures 2005. American Cancer Society (ACS). Atlanta, Georgia. Available at: (www.cancer.gov).
2. Clarke CA, Glaser SL. Changing incidence of non-Hodgkin lymphomas in the United States. Cancer 2002;94:2015-2023.
3. Muller AM, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 2005;84:1-12.
4. Devesa SS, Fears T. Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Research 1992;52(Suppl):5432s-5440s.
5. Ries LAG, Harkins D, Krapcho M, et al., eds. SEER Cancer Statistics Review, 1975-2003. National Cancer Institute. Bethesda, MD. Available at: http://seer.cancer.gov/csr/1975_2003/.
6. Krugman S, Giles JP, Hammon J. Infection hepatitis: evidence for two distinctive clinical, epidemiological and immunological types of infection. JAMA 1967;200:365-373.
7. Summers J, O'Connel A, Millman I. Genome of hepatitis B virus: restriction enzymes cleavage and structure of DNA extracted from Dane particles. Proc Natl Acad Sci U S A 1975;82:4597-4601.
8. Guerrero RB, Roberts LR. The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma. J Heparol 2005;42:760-777.
9. Bruix J, Boix L, Sala M, Llovet JM. Focus on hepatocellular carcinoma. Cancer Cell 2004;5:215-219.
10. Ganem D, Prince AM. Hepatitis B virus infection: natural history and clinical consequences. N Engl J Med 2004;350:1118-1129.
11. Szmuness W. Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog Med Virol 1978;24:40-69.
12. Gisbert JP, Garcia-Buey L, Arranz R, Blas C, Pinilla I, Khorrami S, et al. The prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Eur J Gastroenterol Hepatol 2004;16:135-138.
13. de Sanjose S, Nieters A, Goedert JJ, Domingo-Domenech E, Fernandez de Sevilla A, Bosch,R, et al. Role of hepatitis C virus infection in malignant lymphoma in Spain. Int J Cancer 2004;111:81-85.
14. Engels EA, Chatterjee N, Cerhan JR, Davis S, Cozen W, Severson RK, et al. Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study. Int J Cancer 2004;111:76-80.
15. Harakati MS, Abualkhair OA, Al-Knawy BA. Hepatitis C virus infection in Saudi Arab patients with B-cell non-Hodgkin's lymphoma. Saudi Med J 2000;21:755-758.
16. Zuckerman E, Zuckerman T, Levine AM, Douer F, Gutekunst K, Mizokami M, et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma. Ann Intern Med 1997;127:423-428.
17. Quinn ER, Chan CH, Hadlock KG, Foung SK, Flint M, Levy S. The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 2001;98:3745-3749.
18. Kim JH, Bang YJ, Park BJ, Yoo T, Kim CW, Kim TY, et al. Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: a case-control study. Jpn J Cancer Res 2002;93:471-477.
19. Kuniyoshi M, Nakamuta M, Sakai H, Enjoji M, Kinukawa N, Kotoh K, et al. Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma. J Gastroenterol Hepatol 2001;16:215-219.
20. Cucuianu A, Patiu M, Duma M, Basarab C, Soritau O, Bojan A, et al. Hepatitis B and C virus infection in Romanian non-Hodgkin's lymphoma patients. Br J Haematol 1999;107:353-356.
21. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-619.
22. Saif MW, Little RF, Hamilton JM, Allegra CJ, Wilson WH. Reactivation of chronic hepatitis B infection following intensive chemotherapy and successful treatment with lamivudine: a case teport and review of the literature. Ann Oncol 2001;12:123-129.
23. Shimizu D, Nomura K, Matsumoto Y, Ueda K, Yamaguchi K, Minami M, et al. Hepatitis B virus reactivation in a patient undergoing steroid-free chemotherapy. World J Gastroenterol 2004;10:2301-2302.
24. Tsutsumi Y, Kawamura T, Saitoh S, Yamada M, Obara S, Miura T, et al. Hepatitis B virus reactivation in a case of non-Hodgkin's lymphoma treated with chemotherapy and rituximab: necessity of prophylaxis for hepatitis B virus reactivation in rituximab therapy. Leukemia and Lymphoma 2004;45:627-629.